Login / Signup

Revisiting flow augmentation bypass for cerebrovascular atherosclerotic vaso-occlusive disease: Single-surgeon series and review of the literature.

Jihad AbdelgadirAden P Haskell-MendozaAmanda R MagnoAlexander D SuarezPrince AntwiAlankrita RaghavanPatricia NelsonLexie Zidanyue YangSin-Ho JungAli R Zomorodi
Published in: PloS one (2023)
For patients with high-risk non-Moyamoya VOD who have failed optimal medical therapy, contemporary approaches to flow augmentation with STA-MCA bypass may prevent future ischemic events with a low complication rate.
Keyphrases
  • sickle cell disease
  • soft tissue
  • healthcare
  • current status
  • ischemia reperfusion injury
  • minimally invasive
  • replacement therapy
  • bone marrow